<p>(A) Transplant-related mortality (TRM) in patients with non-advanced disease at the time of BMT. (B) TRM in patients with advanced disease at the time of BMT. (C) Relapse incidences in patients with non-advanced disease at the time of BMT. (D) Relapse incidences in patients with advanced disease at the time of BMT.</p
We previously reported a risk score that predicted mortality in patients with chronic graft-versus-h...
Between January 1985 and March 1992, 48 patients with chronic phase CML underwent BMT from volunteer...
Between 1988 and 1999, 127 patients with poor-risk acute lymphoblastic leukemia (ALL) received a mat...
<p>(A) Overall survival in patients with non-advanced disease at the time of BMT. (B) Overall surviv...
We suggest a new simple approach for estimation and assessment of covariate effects for the cumulati...
AbstractTo assess the effect of related versus unrelated donors on outcomes in patients following T-...
<p>(A) Propensity-score matching of patients. (B) Cumulative incidence curves for death and transpla...
We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse in 283 consec...
We analyzed engraftment of unrelated-donor (URD) bone marrow in 5246 pa-tients who received transpla...
Pre-transplant measurable residual disease (MRD) predicts relapse and outcome of allogeneic haematop...
<p>A) Cumulative incidence curves for cancer incidence, cancer mortality and other causes of death i...
<p>Abbreviations: BMT, bone marrow transplantation; GVHD, graft-versus-host disease.</p><p>Compariso...
Bone marrow transplantation (BMT) is an accepted form of therapy with increasing indications in a va...
Sive care unit (ICU) admission following discharge from bone marrow transplant (BMT) (n = 504); axis...
Cumulative incidence rates for all-cause death/myocardial infarction in overall (A) and matched (B) ...
We previously reported a risk score that predicted mortality in patients with chronic graft-versus-h...
Between January 1985 and March 1992, 48 patients with chronic phase CML underwent BMT from volunteer...
Between 1988 and 1999, 127 patients with poor-risk acute lymphoblastic leukemia (ALL) received a mat...
<p>(A) Overall survival in patients with non-advanced disease at the time of BMT. (B) Overall surviv...
We suggest a new simple approach for estimation and assessment of covariate effects for the cumulati...
AbstractTo assess the effect of related versus unrelated donors on outcomes in patients following T-...
<p>(A) Propensity-score matching of patients. (B) Cumulative incidence curves for death and transpla...
We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse in 283 consec...
We analyzed engraftment of unrelated-donor (URD) bone marrow in 5246 pa-tients who received transpla...
Pre-transplant measurable residual disease (MRD) predicts relapse and outcome of allogeneic haematop...
<p>A) Cumulative incidence curves for cancer incidence, cancer mortality and other causes of death i...
<p>Abbreviations: BMT, bone marrow transplantation; GVHD, graft-versus-host disease.</p><p>Compariso...
Bone marrow transplantation (BMT) is an accepted form of therapy with increasing indications in a va...
Sive care unit (ICU) admission following discharge from bone marrow transplant (BMT) (n = 504); axis...
Cumulative incidence rates for all-cause death/myocardial infarction in overall (A) and matched (B) ...
We previously reported a risk score that predicted mortality in patients with chronic graft-versus-h...
Between January 1985 and March 1992, 48 patients with chronic phase CML underwent BMT from volunteer...
Between 1988 and 1999, 127 patients with poor-risk acute lymphoblastic leukemia (ALL) received a mat...